Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards Reports Strong LifeStent Leg Artery Data, But PMA Will Wait Till ’08

This article was originally published in The Gray Sheet

Executive Summary

Edwards Lifesciences reported positive clinical results for its LifeStent femoral/popliteal stent, but FDA is asking for more bench test data for the product's PMA for the femoral indication

You may also be interested in...



Edwards Sells LifeStent Peripheral Business To Bard For $140 Million

Edwards Lifesciences is giving up on the peripheral vascular market to focus its resources on its heart valve and critical care businesses

Edwards Sells LifeStent Peripheral Business To Bard For $140 Million

Edwards Lifesciences is giving up on the peripheral vascular market to focus its resources on its heart valve and critical care businesses

FDA Rounds Up Biliary Stent Makers On Off-label Promotion

FDA gathered biliary stent manufacturers to discuss how to prevent off-label marketing for peripheral vascular disease while it clarifies the regulatory pathway for vascular stents

Related Content

UsernamePublicRestriction

Register

MT025422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel